Publications by authors named "Victor Amado"

Claim this Profile
P
PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing.
Juan L López-Cánovas, Natalia Hermán-Sánchez, Mercedes Del Rio-Moreno, Antonio C Fuentes-Fayos, Araceli Lara-López, Víctor Amado

Exp Mol Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing.
Juan L López-Cánovas, Natalia Hermán-Sánchez, Maria Trinidad Moreno-Montilla, Mercedes Del Rio-Moreno, Emilia Alors-Perez, Víctor Amado

Clin Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation.
Víctor Amado, Sandra González-Rubio, Javier Zamora, Rafael Alejandre, María Lola Espejo-Cruz

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma.
Juan L López-Cánovas, Mercedes Del Rio-Moreno, Helena García-Fernandez, Juan M Jiménez-Vacas, M Trinidad Moreno-Montilla, Víctor Amado

Cancer Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma.
Gustavo Ferrín, Marta Guerrero, Víctor Amado, Manuel Rodríguez-Perálvarez, Manuel De la Mata

Int J Mol Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation.
Manuel Rodríguez-Perálvarez, Marta Guerrero, Laura De Luca, Beatriz Gros, Douglas Thorburn, Víctor Amado

Transplantation· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation.
Manuel Rodríguez-Perálvarez, Victor Amado, Manuel de la Mata

Aliment Pharmacol Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence.
Marta Guerrero, Gustavo Ferrín, Manuel Rodríguez-Perálvarez, Sandra González-Rubio, Marina Sánchez-Frías, Víctor Amado

Int J Mol Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria.
Víctor Amado, Manuel Rodríguez-Perálvarez, Gustavo Ferrín, Manuel De la Mata

J Hepatocell Carcinoma· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis